Content archived on 2024-06-18

A Modular Nanosystems Platform for Advanced Cancer Management: Nano-vehicles; Tumor Targeting and Penetration Agents; Molecular Imaging, Degradome based Therapy

Nanotechnology for cancer diagnosis and treatment.

Cancer remains the second most common cause of death in the EU despite recent significant advances. The development of more effective targeted therapies could dramatically improve the way we treat the disease.

Keywords

Discover other articles in the same domain of application

Low-dose 3D X-ray imaging opens new horizons

31 October 2019

Neuropathic pain: better understanding risk factors to improve treatment

29 January 2020

Novel toxicology platform brings innovation and safety one step closer

Paving the way for wireless neural implants of the future

Project Information

SAVEME

Grant agreement ID: 263307

Project closed

Start date 1 March 2011

End date 28 February 2015

Funded under

Specific Programme "Cooperation": Nanosciences, Nanotechnologies, Materials and new Production Technologies

Total cost

€ 13 809 085,64

EU contribution

€ 10 500 000,00

10 500 000,00

3 309 085,64

Coordinated by

TEL AVIV UNIVERSITY
Israel

Share this page Share this page on social networks

Download Download the content of the page

XML
PDF

Last update: 22 April 2016

My Booklet

Permalink: https://cordis.europa.eu/article/id/90668-nanotechnology-for-cancer-diagnosis-and-treatment

European Union, 2025